Article

Dopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson’s Disease

2022-12-26

Abstract excerpt

Fecal gut microbiota changes are associated with Parkinson’s disease (PD). However, disease related changes cannot readily be discerned from medication effects, as almost all participants in previous studies were using PD medication, and conclusive longitudinal data related to treatment initiation is lacking. Here, fecal gut microbiota composition was assessed in 62 de novo PD participants who were untreated at ba...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 48147a11-99ea-5a7f-aa6d-ebe3c69ac1d9
DOI: 10.1101/2022.12.23.22283907

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Dopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson’s DiseaseDOI 10.1101/2022.12.23.22283907Read

Fecal microbiome alterations in treatment-naive de novo Parkinson’s diseaseSemantic proximity Read

Microbial Diversity in Drug Naïve Parkinson’s Disease PatientsSemantic proximity Read

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain AxisSemantic proximity Read

Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiotaSemantic proximity Read

A review of studies on gut microbiota and levodopa metabolismSemantic proximity Read

Meta-analysis of the gut microbiome of Parkinson’s disease patients suggests alterations linked to intestinal inflammationSemantic proximity Read

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patientsSemantic proximity Read

Unraveling gut microbiota in Parkinson's disease and atypical parkinsonismSemantic proximity Read

Microbiome changes: an indicator of Parkinson’s disease?Semantic proximity Read

Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relativesSemantic proximity Read

Diet and the gut microbiome in patients with Parkinson’s diseaseSemantic proximity Read

Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa‐carbidopa intrajejunal gelSemantic proximity Read